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Surgery for Renovascular Disease: Long-Term Fol-
low-up of Patients Operated on during Fifteen Years
Johnny Steuer, Martin Björck, Christer Ljungman, Sandra
Jonasson, David Bergqvist. Institution of Surgical Sciences,
Department of Vascular Surgery, Uppsala University, Upp-
sala, Sweden
Objectives: To investigate the early and long-term
outcome after surgery for renovascular disease with empha-
sis on blood pressure control, renal function and survival.
Methods: During the 15-year period 1993-2007, a
total of 40 patients underwent open surgery for renovascu-
lar disease at our institution. The patients were followed for
up to five years with respect to postoperative morbidity,
including nephrectomy, dialysis dependency, vessel pa-
tency, blood pressure (BP) and renal function. Survival was
evaluated by cross-matching all patients with the popula-
tion-registry on Oct 1 2010.
Results: Of the 40 patients, 31 had renal artery steno-
sis, eight due to fibromuscular dysplasia (FMD), and 23
with predominantly atherosclerotic etiology (ARAS). Nine
were operated on for renal artery aneurysm (RAA). 16 of 23
patients with ARAS, 6/8 with FMD and 3/9 with RAA
were women.More than 2/3 of ARAS patients needed 3 or
more antihypertensive drugs, as did 2/3 of FMD patients
prior to surgery. The majority of FMD and RAA patients
had normal renal function, in 2/3 of ARAS patients it was
impaired. In FMD and RAA patients the disease involved
the right renal artery more often, whereas in ARAS patients
the disease was evenly distributed.
In ARAS and FMD patients, BP at 1 month and 1 year
had decreased post- compared to preoperatively, as had the
need for antihypertensive medication. No change in renal
function was observed. During follow-up, three patients
underwent PTRA for re-stenosis. Thirty-day mortality was
2.5%, caused by bowel ischemia in one ARAS patient.
Overall five-year survival was 87%. There was one late death
among FMD patients, 14 years after surgery. All RAA
patients were still alive. In ARAS patients five-year survival
was 78%. Median follow-up was 8.5 years.
Conclusions: Surgery for renovascular disease can be
performed with low morbidity and mortality, as well as a
very low need of re-interventions, and should still be con-
sidered as a therapeutic option in patients with complex
renovascular disease.
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A Contemporary Experience of Open Surgical Treat-
ment of Renal Artery Aneurysms
Paul J. Foley1, Grace J. Wang1, Benjamin M. Jackson1, Ali
Naji1, Jeffrey Carpenter2, Clyde F. Barker1, Ronald M.
Fairman1, Edward Y. Woo1. 1Surgery, University of Penn-
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Objectives: To examine our experience with open
surgical treatment of renal artery aneurysms(RAA).
Methods: All patients undergoing surgical repair of
RAAs between 1995 and 2010 were identified. Medical
records were retrospectively reviewed for comorbidities,
aneurysm characteristics, surgical approach and outcomes.
Results: Thirteen RAAs were identified in 12 patients.
One patient had 2 ipsilateral RAAs. Mean age was 49/
12 years and 11 were female. Two patients had concomi-
tant splenic artery aneurysms. Preoperatively, the mean
number of antiHTNmedications per patient was 1.4. Eight
patients presented with incidental RAAs and the rest had
flank pain. One patient presented with rupture and under-
went nephrectomy. All patients underwent preoperative
cross-sectional imaging, while 7 had angiography as well.
No patient had evidence of atheroemboli, renal infarcts,
renal artery dissection or renal artery stenosis by preopera-
tive imaging. Two patients had anatomically abnormal
contralateral kidneys(congenital absence and atrophy) but
no patients had abnormal renal function(mean Cr 0.8/
0.2 mg/dL). Comorbidities included HTN(7), fibromus-
cular dysplasia(1), and DM(1). The RAAs(mean diameter
2.9 / 1.4 cm; saccular5) were treated by either ex-
vivo reconstruction and autotransplantation(5), resection/
primary anastomosis(5), resection/saphenous vein inter-
position(1), resection/patch angioplasty (1), or
nephrectomy(1). Mean LOS was 6.4/ 1.4 days. Three
patients experienced 4 perioperative complications (ARF
2-both resolved, delirium1 and ureteral anastomotic
leak1). Thirty-day survival was 100%. Mean followup was
40months(7-140). All patients were alive at follow-up with
preserved renal function and no uncontrolled HTN.
Conclusions: Many RAA’s are not amenable to treat-
ment with endovascular techniques. Thus, open surgical
repair is still a mainstay of treatment and can be done with
minimal perioperative morbidity and mortality.
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Objectives: Blunt abdominal aortic injury (BAAI) is
very rare. Current literature is limited to case series of single
center experience. Through an analysis of the National
Trauma Databank (NTBD), the largest aggregation of
United States trauma registry data, our aim was to more
accurately characterize the injury patterns, management
strategy and mortality of patients with BAAI.
Methods: We used a nested case-control design. The
cohort was patients age16 years, with injury severity score
(ISS) 16, treated at a level 1 or 2 trauma center in years
2007-2009. Cases were patients with BAAI and were
matched by age and mechanism to 1815 randomly selected
controls without BAAI. Data collected included age, gen-
der, comorbidities, ISS, associated injuries, type and timing
of vascular interventions and hospital disposition.
Results: We identified 363 patients with BAAI from
156 centers. Themean ISS was 3415 and the average age
was 49 21 years. Most patients were injured in motor
vehicle crashes (84%). In comparison to controls, lumbar
spine fractures, pelvic fractures as well as injuries to the
kidneys, liver, spleen, pancreas, small bowel and colon were
all more frequent in association with BAAI (p0.001).
Mortality was greater in patients with BAAI (32% vs. 10% in
controls, p0.001), with two thirds of deaths occurring in
the first 24 hours.
Of the 286 patients surviving beyond 24 hours,
249 (87%) were managed non-operatively, 26 (9%) under-
went endovascular repair and 11 (4%) underwent open
repair (9 with aortic interposition graft, 2 with extra-ana-
tomic bypass). 81% of repairs were performed within 48
hours. 216 (86%) patients managed non-operatively sur-
vived to hospital discharge.
Conclusions: The index of suspicion for BAAI should
be raised in severely injured patients by the presence of
lumbar and pelvic fractures as well as intra-abdominal in-
jury. While endovascular repair is the most common inter-
vention, most patients are managed non-operatively and
survive to hospital discharge.
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Impact of Pre-Operative Embolization on Outcomes of
Shamblin II and III Carotid Body Tumor Resections
Adam H. Power, Jan Kasperbauer, Harry Cloft, David
Kallmes, Terri Vrtiska, William Young, Audra Duncan,
Peter Gloviczki, Manju Kalra, Gustavo S. Oderich, Thomas
Bower. Vascular Surgery, Mayo Clinic, Rochester, MN
Objectives: To assess neurovascular complications in
the surgical management of carotid body tumors (CBT)
with emphasis on those treated with and without pre-
operative embolization (EMB).
Methods: All CBT resections at a single institution
from 1985 to 2010 were reviewed. Outcomes were com-
pared between Shamblin Groups II and III CBT treated
with (EMB group) and without pre-operative EMB
(NEMB group).
Results: 144 CBT with 12 concurrent cervical paragan-
gliomas were resected in 131 patients (80 females [65%];
mean age 48 years [range, 16-84]; 13 bilateral resections; 32
familial CBT; 17 confirmed SDHx mutations; mean tumor
volume 25.5 cm3 [range, 0.8-101.3]; 2 biochemically active
CBT [1%]). Of these, 71 CBT were classified as Shamblin
Group II and 33 as Shamblin Group III based on pre-opera-
tive imaging, operative findings, and pathology reports. 33
CBT resections were performed in the EMB group and 71 in
the NEMB group. There were more patients in the EMB
groupwith bilateral (42% vs 21%, P.01) and familial (33% vs
24%, P.01) CBT. Otherwise, there were no differences in
patient demographics, Shamblin type, or tumor volumes.
There were no strokes or other major complications after
pre-operative EMB. The EMB group required less extensive
procedures (simple excision in 97% vs 82%, P.03; internal
carotid artery clamping in 15% vs 37%, P.04) and had less
blood loss (mean EBL 263 ml vs 599 ml, P.001) than the
NEMBgroup.However, therewas no significant difference in
operative time (250 minutes vs 265 minutes, P.49), tran-
sient cranial nerve injury (52% vs 38%, P.21), clinically
apparent cranial nerve deficits after 1 year (12% vs 4%, P.20),
mortality (0% vs 0%, PNS), stroke (0% vs 1%, PNS), or
post-op length of stay (4.1 vs 4.2 days, P.91).
Conclusions: Large carotid body tumors can be re-
sected safely with or without pre-operative embolization.
Pre-operative embolization may simplify the conduct of
CBT resection and reduce blood loss but it does not
decrease the incidence of cranial nerve injury.
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